Your browser doesn't support javascript.
loading
Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon?
Musacchio, L; Cicala, C M; Camarda, F; Ghizzoni, V; Giudice, E; Carbone, M V; Ricci, C; Perri, M T; Tronconi, F; Gentile, M; Salutari, V; Scambia, G; Lorusso, D.
Affiliation
  • Musacchio L; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. Electronic address: https://twitter.com/lucia_musacchio.
  • Cicala CM; Department of Medical and Surgical Science, Medical Oncology Unit, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. Electronic address: https://twitter.com/carlomcicala.
  • Camarda F; Department of Medical and Surgical Science, Medical Oncology Unit, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. Electronic address: https://twitter.com/florianacamarda.
  • Ghizzoni V; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Giudice E; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Carbone MV; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Ricci C; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Perri MT; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Tronconi F; Medical Oncology Unit, Marche Polytechnic University, Ancona, Italy.
  • Gentile M; Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy.
  • Salutari V; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Scambia G; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Department of Life Science and Public Health, Catholic University of Sacred Heart Largo Agostino Gemelli, Rome, Italy.
  • Lorusso D; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Department of Life Science and Public Health, Catholic University of Sacred Heart Largo Agostino Gemelli, Rome, Italy. Electronic address: domenica.loruss
ESMO Open ; 7(4): 100536, 2022 08.
Article in En | MEDLINE | ID: mdl-35849879
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Poly(ADP-ribose) Polymerase Inhibitors Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: ESMO Open Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Poly(ADP-ribose) Polymerase Inhibitors Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: ESMO Open Year: 2022 Document type: Article